These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2594825)

  • 1. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of oral sustained-action preparations with a base of biologically degradable polymers. 2. Preparation of matrix tablets with a base of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 May; 44(5):328-30. PubMed ID: 2772012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparations of preoral sustained-release preparations with a biological polymer base. 5 (correct title supplied from Table of Contents)].
    Keipert S; Siebenbrodt I
    Pharmazie; 1990 Jul; 45(8):594-5. PubMed ID: 2080206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
    Guyonnet T; Brossard C; Lefort des Ylouses D
    J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
    Gavini E; Sanna V; Juliano C; Giunchedi P
    J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of peroral sustained release drug forms on a base of biodegradable polymers. 1. Preparation and characterization of polylactic acid].
    Mank R; Kala H; Richter M
    Pharmazie; 1989 Apr; 44(4):276-9. PubMed ID: 2772002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The control of drug release of heavy-soluble, weak basic drugs in matrix tablets using the example of medazepam].
    Zessin G; Fahr F; Mank R
    Pharmazie; 1986 Jan; 41(1):39-42. PubMed ID: 2870512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components.
    Zgoda MM; Woskowicz M; Nachajski M; Haeusler O; Iwanczyk M
    Pharmazie; 2004 Aug; 59(8):651-3. PubMed ID: 15378860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
    Goole J; Vanderbist F; Amighi K
    Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparations of matrix tablets from a polyacrylate base].
    Mank R; Zessin G; Fahr F
    Pharmazie; 1986 Jan; 41(1):42-4. PubMed ID: 3960947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments.
    Touitou E; Alhaique F; Riccieri FM; Riccioni G; Santucci E
    Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.